Niagen Bioscience A.G.P. Virtual Consumer Showcase
Review the key takeaways and the transcript of this earnings call.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Welcome to another session of A.G.P.'s Consumer Showcase. Really excited for the next company we have in store, Niagen Bioscience. We have CEO Rob Fried, as well as CFO Ozan Pamir. Ozan, Rob, thanks so much for joining me.
Thanks, Aaron. All right. If you guys have any questions for the Niagen team, go and type those into the Q&A, and we'll try and get those answered during the session or at the end.
To kick things off, it'd be great for you to give us an overview of the Niagen Bioscience story, as some of the listeners may be new to the name here.
Niagen Bioscience has been in business about 25 years. Started as a standards testing company, ingredients testing service, pivoted into the ingredient business. One of the ingredients that it patented was called nicotinamide riboside, which is probably the most consequential new ingredient to have emerged in the dietary supplement ingredient industry in the last 30 or 40 years. Nicotinamide riboside, that we call Niagen, is an outstanding precursor to something called NAD, which stands for nicotinamide adenine dinucleotide. There are other ways to elevate NAD, but none are as efficient or as safe or as researched as Niagen. NAD is vital to the health of all living cells, plant and animal. All living cells have NAD in it. All important metabolic functions require NAD to function properly, and the more saturated a cell is with NAD, the better it functions.
The primary functions that we look to are energy metabolism, mitochondrial function. You have more mitochondria when you have lots of NAD. It increases mitochondrial biogenesis and better output per mitochondria. Perhaps more important is cellular resilience, the ability of the cells to repair damage, inflammation, oxidative stress, gene mutations or damage, the presence of virus. When the cell manages those problems, it is all NAD dependent. As we age, cells become increasingly damaged. The diminished ability to repair that damage is ultimately what causes aging, and that is why it has become so popular as an anti-aging phenomenon. It works in that regard. Niagen Bioscience is a company presently that is now focused solely on NAD and healthy aging products. We sell nicotinamide riboside, or Niagen, as a dietary supplement. That is Tru Niagen, and we are gradually expanding that consumer products division. We have recently added a skincare product. We call them NanoCloud. It is Niagen that you can apply directly to the skin.
We also have an IV and an injection business, or a telehealth business, if you will, where you can actually inject or get an IV of pharmaceutical-grade Niagen, either at clinics or at home. We also supply Niagen as an ingredient, food grade or pharmaceutical grade, to other dietary supplement companies. Ultimately, what we have been working on for many, many, many years, and we have made great progress on, is a prodrug version of nicotinamide riboside. We call it NB4168, which works far more efficiently than traditional nicotinamide riboside, which we are developing as a rare disease drug for these orphan diseases where children age extremely rapidly.
It turns out that these diseases, and there are quite a few of them, ataxia telangiectasia is one we are focusing on, but there is also Werner syndrome, citrin deficiency, mitochondrial myopathy, other forms of ataxia, where children age very rapidly, and it turns out in most of these cases, these children have non-detectable levels of NAD. This is a real material example of the relationship between NAD levels and the way the body ages. We sort of all have a form of this disease. As we age and our NAD levels decline, our bodies age. We have made great progress in the orphan disease space of advancing this molecule toward drug approval in that space. That is Niagen Bioscience. It has got several verticals all attacking the nicotinamide riboside Niagen space, but all from different modalities and different approaches.
Really appreciate that overview, Rob. We are going to dive into some of those verticals here today. Maybe to kick things off, interest in NAD+ and longevity has grown significantly. Can you talk about the size and growth of the category, and what differentiates Niagen or NR from other NAD+ precursors?
Yeah. I mean, we believe that we are the primary reason the category has taken off as it has. Most companies that sell a dietary supplement maybe will do one or two clinical studies, if you will. To date, we have had 52 peer-reviewed published clinical studies on Niagen and nicotinamide riboside, and there are another 30 presently going on in the clinic. I mean, we are a very, very highly advanced R&D science-based company. I think NAD probably as a dietary supplement market globally is probably in the $3 billion range at this point. When we started this thing eight to 10 years ago, it was maybe a $10 million market. I mean, it has grown precipitously because people are interested in aging better, and the science is very compelling, uniquely compelling, not only from a mechanistic standpoint, but also from a peer-reviewed published study standpoint.
The best way to elevate NAD, the safest way to elevate NAD is with Niagen, with nicotinamide riboside. There are other molecules out there that can elevate NAD, not as safely, not as efficiently, not as well. There are many products that have recently emerged in the marketplace that do not do it at all, but still make that claim. But the best, most efficient, and safest way to do it is with Niagen. I can explain to you exactly scientifically why that is the case, mechanistically why that is the case. The industry itself mostly consists of three main ingredients: nicotinamide riboside, also known as Niagen, also known as NR, which we have patented and control. There is one called NMN, nicotinamide mononucleotide, which does not have a transporter, cannot get into cells.
The reason why NMN does work, however, is because as it circulates through your bloodstream and through your liver and back through your bloodstream, it metamorphosizes and breaks apart into smaller molecules, one of which is actually nicotinamide riboside. NMN is a delivery mechanism for a smaller dose of nicotinamide riboside. That process, though, in the long term, may not be as safe. There is an enzyme called CD38, which is associated with damaged, old, inflamed cells. NMN actually is a substrate for CD38, whereas Niagen actually inhibits CD38. The presence of CD38 may not be obvious in a couple of months, but over the course of a year or two, it may be. Then the third ingredient that I would say is in the NAD space is NAD itself. Oddly, that is actually the largest category of the three. Many people literally take NAD as an ingredient.
This is not a good idea. There are zero studies that show taking NAD actually elevate NAD. There are many studies that show it creates inflammation because it has no way of getting into the cell. Whereas NMN breaks apart and a little bit of NMN turns into NR and does get into the cell, it is not the case with NAD. Many people are actually injecting or getting IVs of NAD. If you know anyone who has done it, they will tell you, "It took me three hours. I had to break out in sweats, and I had chest pains." That is because NAD is not bioavailable. Niagen, however, if you take through an IV, will just take a few minutes, has very high elevation levels of NAD, and does not have those side effects. So, it is the best molecule. The science is the best around NR or Niagen.
The challenge for us as a business is educating the general consumer about those facts.
Okay, I really appreciate that. Let's talk about your branded product, Tru Niagen, roughly a $100 million business today. Can you talk about the different sales channels you sell through, including your own website and third-party e-commerce like Amazon, as well as brick-and-mortar retail?
Yeah, the bulk of the Tru Niagen business is Amazon and our website. We also sell it in parts of Asia in a retail chain called Watsons, and we are in limited retail here in the U.S. That is the bulk of the Tru Niagen distribution business. It is about a $100 million dietary supplement, and that makes it, as a single SKU dietary supplement, one of the two or three biggest-selling dietary supplements in the country. Our opportunity is to take that single supplement ingredient and build around it a wider portfolio of dietary supplements and skincare products. As I said before, we also sell Niagen to certain select companies as an ingredient, and they put Niagen in some of their dietary supplements. So, there are certain brands, if it says Niagen, you can trust it.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.
View the full transcript with ProCall participants
2 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
